243 related articles for article (PubMed ID: 27803164)
1. Helenalin Acetate, a Natural Sesquiterpene Lactone with Anti-inflammatory and Anti-cancer Activity, Disrupts the Cooperation of CCAAT Box/Enhancer-binding Protein β (C/EBPβ) and Co-activator p300.
Jakobs A; Steinmann S; Henrich SM; Schmidt TJ; Klempnauer KH
J Biol Chem; 2016 Dec; 291(50):26098-26108. PubMed ID: 27803164
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
3. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65.
Lyss G; Knorre A; Schmidt TJ; Pahl HL; Merfort I
J Biol Chem; 1998 Dec; 273(50):33508-16. PubMed ID: 9837931
[TBL] [Abstract][Full Text] [Related]
4. Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaB.
Lyss G; Schmidt TJ; Merfort I; Pahl HL
Biol Chem; 1997 Sep; 378(9):951-61. PubMed ID: 9348104
[TBL] [Abstract][Full Text] [Related]
5. A synthetic covalent ligand of the C/EBPβ transactivation domain inhibits acute myeloid leukemia cells.
Abdel Ghani L; Yusenko MV; Frank D; Moorthy R; Widen JC; Dörner W; Khandanpour C; Harki DA; Klempnauer KH
Cancer Lett; 2022 Apr; 530():170-180. PubMed ID: 35077804
[TBL] [Abstract][Full Text] [Related]
6. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
[TBL] [Abstract][Full Text] [Related]
7. Withaferin A, a natural compound with anti-tumor activity, is a potent inhibitor of transcription factor C/EBPβ.
Falkenberg KD; Jakobs A; Matern JC; Dörner W; Uttarkar S; Trentmann A; Steinmann S; Coulibaly A; Schomburg C; Mootz HD; Schmidt TJ; Klempnauer KH
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1349-1358. PubMed ID: 28476645
[TBL] [Abstract][Full Text] [Related]
8. Regulation of adipocyte 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) by CCAAT/enhancer-binding protein (C/EBP) β isoforms, LIP and LAP.
Esteves CL; Kelly V; Bégay V; Man TY; Morton NM; Leutz A; Seckl JR; Chapman KE
PLoS One; 2012; 7(5):e37953. PubMed ID: 22662254
[TBL] [Abstract][Full Text] [Related]
9. P53 regulates CCAAT/Enhancer binding protein β gene expression.
Hu B; Liu T; Wu Z; Phan SH
Gene; 2023 Oct; 884():147675. PubMed ID: 37541559
[TBL] [Abstract][Full Text] [Related]
10. Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells.
Christian M; Pohnke Y; Kempf R; Gellersen B; Brosens JJ
Mol Endocrinol; 2002 Jan; 16(1):141-54. PubMed ID: 11773445
[TBL] [Abstract][Full Text] [Related]
11. Interaction and cooperation of the CCAAT-box enhancer-binding protein β (C/EBPβ) with the homeodomain-interacting protein kinase 2 (Hipk2).
Steinmann S; Coulibaly A; Ohnheiser J; Jakobs A; Klempnauer KH
J Biol Chem; 2013 Aug; 288(31):22257-69. PubMed ID: 23782693
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.
Gutsch R; Kandemir JD; Pietsch D; Cappello C; Meyer J; Simanowski K; Huber R; Brand K
J Biol Chem; 2011 Jul; 286(26):22716-29. PubMed ID: 21558273
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP).
Lee S; Miller M; Shuman JD; Johnson PF
J Biol Chem; 2010 Jul; 285(28):21399-410. PubMed ID: 20452968
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein).
Martínez-Jiménez CP; Gómez-Lechón MJ; Castell JV; Jover R
Mol Pharmacol; 2005 Jun; 67(6):2088-101. PubMed ID: 15778453
[TBL] [Abstract][Full Text] [Related]
15. The C/EBPβ LIP isoform rescues loss of C/EBPβ function in the mouse.
Bégay V; Baumeier C; Zimmermann K; Heuser A; Leutz A
Sci Rep; 2018 May; 8(1):8417. PubMed ID: 29849099
[TBL] [Abstract][Full Text] [Related]
16. Role of C/EBPβ-LAP and C/EBPβ-LIP in early adipogenic differentiation of human white adipose-derived progenitors and at later stages in immature adipocytes.
Lechner S; Mitterberger MC; Mattesich M; Zwerschke W
Differentiation; 2013 Jan; 85(1-2):20-31. PubMed ID: 23314288
[TBL] [Abstract][Full Text] [Related]
17. NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death.
Lim CB; Fu PY; Ky N; Zhu HS; Feng X; Li J; Srinivasan KG; Hamza MS; Zhao Y
BMC Complement Altern Med; 2012 Jul; 12():93. PubMed ID: 22784363
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.
Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y
Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130
[TBL] [Abstract][Full Text] [Related]
19. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
[TBL] [Abstract][Full Text] [Related]
20. v-Myc inhibits C/EBPbeta activity by preventing C/EBPbeta-induced phosphorylation of the co-activator p300.
Steinmann S; Schulte K; Beck K; Chachra S; Bujnicki T; Klempnauer KH
Oncogene; 2009 Jul; 28(26):2446-55. PubMed ID: 19448669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
